Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Diphtheria (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Diphtheria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provid...
September 2021
93 pages
Fanconi Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Fanconi Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provid...
September 2021
93 pages
Gastritis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Gastritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides a...
September 2021
99 pages
Glycoprotein 41 (gp41) - Drugs in Development, 2021
US$ 3,500.00
Glycoprotein 41 (gp41) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitute...
September 2021
67 pages
Impetigo (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Impetigo (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides a...
September 2021
45 pages
Malaria (Infectious Disease) - Drugs in Development, 2021
US$ 2,500.00
Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an...
September 2021
450 pages
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...
September 2021
88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...
September 2021
53 pages
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021
US$ 2,000.00
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 202...
September 2021
113 pages
Tularaemia (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Tularaemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provid...
September 2021
44 pages
Estrogen Receptor Beta - Drugs In Development, 2021
US$ 3,500.00
Estrogen Receptor Beta - Drugs In Development, 2021 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Drugs In Development, 2021'; Estrogen Receptor Beta (ER Beta or Nuclear...
August 2021
77 pages
